Navigation Links
Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman
Date:4/10/2008

BASKING RIDGE, N.J., April 10 /PRNewswire-FirstCall/ -- Hooper Holmes (Amex: HH) today announced that Roy H. Bubbs has been appointed President and Chief Executive Officer and that Benjamin A. Currier will continue as Chairman of the Board of Directors. Mr. Bubbs, who has been a member of the Board since May 30, 2007, had been named to the position of President and CEO on an interim basis on February 6, 2008.

John W. Remshard, who had previously been named Chairman-Elect, continues as Chairman of the Audit Committee and member of the Governance/Nominating Committee of the Board of Directors. These roles allow him to make the greatest contribution to the Board through his extensive financial background, reflecting today's challenging economic climate.

Mr. Currier has joined the committee of Directors exploring the Company's strategic alternatives. Mr. Currier and Mr. Remshard's appointments are subject to their respective elections as Directors at the next Annual Meeting of shareholders.

About Hooper Holmes

Hooper Holmes is the leader in collecting personal health data and transforming it into useful information, enabling customers to take actions that manage or reduce their risks and expenses. As the leading provider of risk assessment services for the insurance industry, Hooper Holmes provides insurers with the widest range of medical exam, data collection, laboratory testing and underwriting services in the industry.

With presence in over 250 markets and a network of thousands of examiners, Hooper Holmes can arrange a medical exam anywhere in the U.S. and deliver the results to its customers. Each year we arrange more medical exams than any other company and process 3.8 million specimens in our laboratory. We provide a complete service for wellness, disease management, and managed care companies including scheduling support, fulfillment of supplies, blood collection kits, medical screenings, lab testing and data transmission. We underwrite 300,000 cases annually and complete more than two million telephone interviews. We are also a leading provider of medical claims evaluation services used by property and casualty insurance carriers, law firms, self- insureds and third-party administrators to handle personal injury and accident claims.

Certain information contained herein includes information that is forward- looking. The matters referred to in forward-looking statements may be affected by the risks and uncertainties involving the Company's business. These forward-looking statements are qualified in their entirety by cautionary statements contained in the Company's Securities and Exchange Commission filings. The Company disclaims any obligation to update these forward-looking statements.

This press release contains "forward-looking" statements, as such term is defined in the Private Securities Litigation Reform Act of 1995. Forward- looking statements included in this press release include, without limitation, the expected reductions in expenses through productivity improvements. These forward-looking statements are based on the Company's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions. Among the important factors that could cause actual results to differ materially from those expressed in, or implied by, these forward-looking statements are our ability to successfully implement our business strategy; uncertainty as to our working capital requirements over the next 12 to 24 months; our ability to maintain compliance with the financial covenants in our credit facility; our expectations regarding our operating cash flows; and the rate of life insurance application activity. Additional information about these and other factors that could affect the Company's business is set forth in the Company's annual report on Form 10-K for the year ended December 31, 2007, filed with the Securities and Exchange Commission on March 14, 2008. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release to reflect the occurrence of unanticipated events, except as required by law.


'/>"/>
SOURCE Hooper Holmes
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information
2. Hooper Holmes to Provide Business Update
3. Hooper Holmes Updates Guidance
4. Hooper Holmes Marks 50,000 Health and Wellness Screenings
5. Hooper Holmes Announces Third Quarter 2007 Results
6. Hooper Holmes Appoints Leslie Hudson, PhD, to Board of Directors
7. Hooper Holmes Announces Third Quarter Earnings Release Date and Conference Call Information
8. Hooper Holmes Introduces Mature Assessment
9. Hooper Holmes to Exhibit at the 2007 Sixth Annual Association of Home Office Underwriters Conference
10. Hooper Holmes Concludes Sale of Medicals Direct
11. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... ... Immunotherapy has emerged as one of the most promising options for the ... next revolution in our fight against this complex disease. One of the most effective ... such as PD-1 and PD-L1 inhibitors. , While a few single analyte immunohistochemistry tests ...
(Date:3/29/2017)... PA (PRWEB) , ... March 29, 2017 , ... The ... W’80, WG’81, and Julie Taffet Moelis, W’81, have made a $10 million gift to ... deferred admission opportunity that will provide a pathway to a Wharton MBA for highly-qualified ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Tuesday, March 28, ... American public to take the Diabetes Risk Test to find out if they are ... Angeles World Airports will light up the evening sky by programming the LAX pylons ...
(Date:3/28/2017)... ... 28, 2017 , ... Resoundant, Inc., the developer of ... Healthineers annual customer education symposium, a world-class learning conference that offers educational content ... - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 Neurim Pharmaceuticals ("Neurim") and ... exclusive marketing rights for Neurim,s new Rx PedPRM in ... ... sleep disorders in children with Autism Spectrum Disorders (ASD) and neurogenetic ... for children. The collaboration with Exeltis will help increase ...
(Date:3/29/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The global patient safety and risk management software ... geography. Patient safety has become a priority for ... developed significantly in the last decade and is currently on the ...
(Date:3/28/2017)... Md. , March 28, 2017 ... Dupixent (dupilumab) injection to treat adults with moderate-to-severe ... whose eczema is not controlled adequately by topical ... not advisable. Dupixent can be used with or ... Dupixent demonstrates our commitment to approving new and ...
Breaking Medicine Technology: